title: Live-donor liver transplantation: the USC experience.
abstract: BACKGROUND
  Liver transplantation is currently the standard of care for patients with end stage liver disease. However due to the cadaveric organ shortage, live donor liver transplantation (LDLT), has been recently introduced as a potential solution. We analyzed and support our initial experience with this procedure at USC.
  
  
  METHODS
  From September 1998 until July 2000, a total of 27 patients underwent LDLT at USC University Hospital and Los Angeles Children's Hospital. There were 12 children with the median age of 10 months (4-114) and 15 adults with the median age of 56 years (35-65). The most common indication for transplantation was biliary atresia for children and hepatitis C for adults.
  
  
  RESULTS
  All donors did well postoperatively; the median postoperative stay was five days (5-7) for left lateral segmentectomy and seven days (4-12) for lobar donation. None of the donors required blood transfusion, re-operation or postoperative invasive procedure. However, five of them (18%) experienced minor complications. The survival rate in pediatric patients was 100% and only one graft was lost at nine months due to rejection. Two adult recipients died in the postoperative period, one from graft non-function and one from necrotizing fascitis. 37% of adult recipients experienced postoperative complications, mainly related to biliary reconstruction. Also 26% of the recipients underwent reoperation for some of these complications.
  
  
  CONCLUSIONS
  LDLT is an excellent alternative to cadaveric transplantation with excellent results in the pediatric population. However, in adult patients it still carries a significant complication rate and it should be used with caution.
authors.affiliation: Department of Surgery, Children's Hospital, Los Angeles, California, USA.
authors.forename: N
authors.initials: N
authors.lastname: Jabbour
authors.forename: Y
authors.initials: Y
authors.lastname: Genyk
authors.forename: R
authors.initials: R
authors.lastname: Mateo
authors.forename: C
authors.initials: C
authors.lastname: Peyre
authors.forename: R V
authors.initials: RV
authors.lastname: Patel
authors.forename: D
authors.initials: D
authors.lastname: Thomas
authors.forename: P
authors.initials: P
authors.lastname: Ralls
authors.forename: S
authors.initials: S
authors.lastname: Palmer
authors.forename: G
authors.initials: G
authors.lastname: Kanel
authors.forename: R R
authors.initials: RR
authors.lastname: Selby
mesh_terms: D000328:Adult; D000368:Aged; D002140:California; D002648:Child; D002675:Child, Preschool; D005260:Female; D006085:Graft Survival; D006785:Hospitals, University; D006801:Humans; D007223:Infant; D007902:Length of Stay; D008107:Liver Diseases / Q000401:mortality / Q000601:surgery*; D016031:Liver Transplantation; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome